miR‐205 modulates tumor cell sensitivity to MET‐TKIs

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Impact of triple combination of gemcitabine‐based chemoirradiation with anti‐PD‐L1 in the KPC tumor allograft Impact of triple combination of gemcitabine‐based.
Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted ES cells on LIF withdrawal. Myc‐induced miRNAs attenuate differentiation of c‐Myc‐depleted.
Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.
Network protein vulnerability in EGFR TKI‐resistant cells and specific for EGFR‐mutated cells. Network protein vulnerability in EGFR TKI‐resistant cells.
Hydroxytyrosol modulates the levels of microRNA-9 and its target sirtuin-1 thereby counteracting oxidative stress-induced chondrocyte death  S. D'Adamo,
Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.
The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth A22Rv1.
Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo
Expression levels of the transgenic DIA1(R1204X) mutant in the inner ear of TG mice Expression levels of the transgenic DIA1(R1204X) mutant in the inner.
The absence of COL6 in PyMT mice sensitizes tumours to cisplatin treatment.A.Eleven week old FP635/PyMT and FP635/PyMT/COL6−/− mice were given cisplatin.
Metabolic profile of Tfe3 KO mice fed a HFD
ADAM8 maintains the aggressive phenotype of TNBC cells in 3D‐culture A–DCells were transfected with siRNAs as in Fig 2D and E for 24 h, and tested for.
RIDD of miRNA (miRIDD) signals in GBM
Expression of FUT9 supports tumor development
Effects of GM1 on astroglial and microglial markers
TFE3 prevents diet‐induced obesity and metabolic syndrome
Reconstitution of Drp1‐E2F5 binding using an E2F5 peptide mimetic enhances ceramide‐mediated lethal mitophagy in HPV(−) HNSCC cells and tumor xenografts.
Expression of PD‐1 on PBMC and malignant exudate T cells
TCF19 is required for survival of NRAS‐mutant melanoma cells
SOM230 increases in vivo sensitivity to gemcitabine of tumour xenograft (MIA PaCa‐2‐Luc cells and CAFs or human PDAC resection) A–CMIA PaCa‐2‐GLuc cells.
Identification of miR‐499 targets
Effect of HUWE1 on MYC and MIZ1 complexes Immunoblot documenting levels of MYC and MIZ1 upon HUWE1 overexpression. Effect of HUWE1 on MYC and MIZ1 complexes.
CDK6 and FOXO3 regulate ATR expression and protect platinum‐treated cells from premature chromosome condensation (PCC)‏ CDK6 and FOXO3 regulate ATR expression.
BRD4 expression levels are associated with sensitivity to BET inhibition in NRAS‐mutant melanoma BRD4 expression levels are associated with sensitivity.
SEMA3C silencing inhibits CRPC cell growth and induces apoptosis
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Inhibition of CDK6 kinase activity sensitizes EOC cells to platinum in vitro Inhibition of CDK6 kinase activity sensitizes EOC cells to platinum in vitro.
Neutralizing endotrophin activity with monoclonal antibodies sensitizes tumours to cisplatin treatment.A.Pieces of tumours from PyMT mice were implanted.
BETi potentiate the efficacy of MEKi in NRAS‐mutant melanoma
Nec‐1 inhibits the phosphorylation and aggregation of tau
Fig. 4. Improved tumor response to docetaxel in TNBC and trastuzumab in HER2-amplified PDX models with the addition of S Improved tumor response.
BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells  Duc-Hiep Bach,
HMGB1 reverses mitochondrial DNA damage caused by mutant Atxn1 The mitochondrial DNA amplification assay with cerebellar tissue revealed that mitochondrial.
Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+ tumors Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+
PERK activator decreases pathological tau species in vitro
IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.
Impact of ONX 0914 on abundance and dissemination of monocytes/macrophages during CVB3 infection Impact of ONX 0914 on abundance and dissemination of monocytes/macrophages.
MET inhibition promotes p21 nuclear translocation
Characterization of MET‐addicted cells rendered resistant to MET tyrosine kinase inhibitors Characterization of MET‐addicted cells rendered resistant to.
STARD3‐mediated cholesterol accumulation in endosomes occurs at the expense of plasma membrane STARD3‐mediated cholesterol accumulation in endosomes occurs.
EnAd‐EpCAMBiTE shows reproducible activity within an expanded cohort of patient malignant peritoneal and pleural exudates EnAd‐EpCAMBiTE shows reproducible.
HPV‐E7 targets RB for induction of ceramide‐dependent mitophagy
Fig. 7. mRIPO therapy restricts tumor growth and produces antigen-specific antitumor immunity. mRIPO therapy restricts tumor growth and produces antigen-specific.
In vivo efficacy of Olaparib in PTEN deficient xenografts.
Fig. 3. TKI sensitivity assessed by the MANO method.
GPR120 deficiency alters the expression of genes involved in glucose and lipid metabolism in BAT GPR120 deficiency alters the expression of genes involved.
Limited transcriptomic changes upon HOTAIR RNA overexpression in MDA‐MB‐231 breast cancer cells Limited transcriptomic changes upon HOTAIR RNA overexpression.
The CHCH domain is necessary for mitochondrial import of CHCHD10
Analysis of OXA1L depletion in D
KLF4 regulates the EndMT switch in CCM1 KO ECs
XBP1s and RIDD of mRNA signals in GBM
Re‐expression of the AXIN1 coding sequence re‐sensitizes VACO6R cells to PORCN inhibition Re‐expression of the AXIN1 coding sequence re‐sensitizes VACO6R.
Growth of TKI‐resistant EGFR delE746‐A750 PC‐9 NSCLC cells is associated with elevated cellular free fatty acid and expression of FASN, and is suppressed.
Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.
Tissue‐specific differences in the levels of CoQ9, CoQ10, and DMQ9, and in the DMQ9/CoQ9 ratio after β‐RA treatment in Coq9R239X mice Tissue‐specific differences.
Impact of ONX 0914‐induced neutrophilia during CVB3 infection
Effect of D‐Asp treatment on myelination and remyelination in cerebellar organotypic slices Effect of D‐Asp treatment on myelination and remyelination.
GM1 decreases neuropathology and weight loss in R6/2 mice
P2X4R blockade increases pro‐inflammatory gene expression after EAE
Nilotinib inhibits DDR1 invasive activity of patient‐derived CRC cells
The oligoclonal antibody overcomes the C797S mutation‐mediated resistance to osimertinib The oligoclonal antibody overcomes the C797S mutation‐mediated.
ADAM8 is induced by hypoxia and promotes angiogenesis ASixteen h after plating, cells were cultured under normoxic (−) or hypoxic (+, 1% O2) conditions.
Limiting neutrophilic inflammation during active phase (ZT13) reduces MI damage Limiting neutrophilic inflammation during active phase (ZT13) reduces MI.
Absence of miR‐21 in macrophages promotes foam cell formation
SEMA3C regulates prostate cancer cell growth
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Active AR signaling in enzalutamide-resistant xenograft tumors.
Biological effects of BRAF silencing: growth curves of A375 (A) and ARO (B) cell lines in the absence or presence of doxycycline. Biological effects of.
FGFR2 amplification in primary human gastric tumors predicts for response to NVP-BGJ398. FGFR2 amplification in primary human gastric tumors predicts for.
Presentation transcript:

miR‐205 modulates tumor cell sensitivity to MET‐TKIs miR‐205 modulates tumor cell sensitivity to MET‐TKIs A–CMiR‐205 expression was silenced by transfection of either anti‐miR‐205 or control antagomiR (Ctrl) in EBC‐1 (A), GTL16 (B), and SG16 (C) resistant cells. Resistant cells were grown in the presence of the TKI to which they are resistant; viability was assessed after 72 h by CellTiterGlo. n = 4 per condition.D–FMiR‐205 or a control miRNA (Ctrl miR, a random miRNA sequence) was over‐expressed in parental (wt) EBC‐1 (D), GTL16 (E), and SG16 (F) cells. Cells were grown for 72 h in the presence of MET‐TKIs at the indicated doses. Viability was evaluated as above. n = 4 per condition.GGTL16 R‐CRIZ cells transduced with pCDH‐anti‐miR‐205 or pCDH (control vector) were subcutaneously injected in NOD/SCID mice. Mice were treated with crizotinib (25 mg/kg), and tumor volume was monitored for 18 days as indicated. n = 6 per condition.HGTL16 wt cells transduced with pCDH‐miR‐205 or with the control vector (pCDH) were injected in NOD/SCID mice. When tumors reached an average volume of around 150 mm3, treatment with either crizotinib (12.5 mg/kg) or vehicle was started. Tumor volume was monitored for 18 days as indicated. n = 6 per condition.IWestern blot analysis of EBC‐1, GTL16, and SG16 cells, either parental (wt, untreated or treated for 2 h with the indicated TKIs) or TKI‐resistant (either in the presence or absence of the TKIs to which they are resistant). Cell lysates were probed with the indicated antibodies. Actin was used as loading control (one actin panel for each WB performed/cell line). Drug abbreviation is as shown in Fig 1.JThe transcriptome of crizotinib‐sensitive/resistant pairs of GTL16 and EBC‐1 cells was determined by RNA‐Seq. The mRNA heatmap shows the expression levels of the predicted miR‐205 targets (TargetScan 7.1) downregulated in resistant versus wt cells. For each gene, the log2 of the RSEM expected counts was converted to the log2 ratio against the global median expression of the gene in all samples. Log2 ratio values were loaded in GEDAS software to perform hierarchical clustering analysis and represent data in a heatmap. Units (−1.5 to +1.5) represent the log2 ratio against the median. Red and blue colors represent the highest and lowest ends of mRNA expression levels, respectively.Data information: (A–H) Data are presented as mean ± SD. Asterisks: ***P < 0.001; **P < 0.01; *P < 0.05. Two‐tailed t‐test was used for panels (A–C, F); two‐way ANOVA, Bonferroni's multiple comparisons test was used for panels (D, E, G, H).Source data are available online for this figure. Cristina Migliore et al. EMBO Mol Med. 2018;emmm.201708746 © as stated in the article, figure or figure legend